» Articles » PMID: 28222333

Immunoprofiling As a Predictor of Patient's Response to Cancer Therapy-promises and Challenges

Overview
Publisher Elsevier
Date 2017 Feb 22
PMID 28222333
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cell infiltration is common to many tumors and has been recognized by pathologists for more than 100 years. The application of digital imaging and objective assessment software allowed a concise determination of the type and quantity of immune cells and their location relative to the tumor and, in the case of colon cancer, characterized overall survival better than AJCC TNM staging. Subsequently, expression of PD-L1, by 50% or more tumor cells, identified NSCLC patients with double the response rate to anti-PD-1. Soon, automated staining methods will improve reproducibility of multiplex staining and allow for CLIA standards so that multiplex staining can be used to make clinical decisions. Ultimately, machine-learning algorithms will help interpret data from tissue images and lead to improved delivery of precision medicine.

Citing Articles

Artificial Intelligence in Point-of-Care Biosensing: Challenges and Opportunities.

Flynn C, Chang D Diagnostics (Basel). 2024; 14(11).

PMID: 38893627 PMC: 11172335. DOI: 10.3390/diagnostics14111100.


A novel CD8+ T cell-related gene signature as a prognostic biomarker in hepatocellular carcinoma.

Peng X, Lu X, Yang D, Liu J, Wu H, Peng H Medicine (Baltimore). 2024; 103(11):e37496.

PMID: 38489709 PMC: 10939595. DOI: 10.1097/MD.0000000000037496.


Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.

Schardey J, Lu C, Neumann J, Wirth U, Li Q, Jiang T Cancers (Basel). 2023; 15(19).

PMID: 37835436 PMC: 10571767. DOI: 10.3390/cancers15194743.


Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease.

Yoo J, Jo S, Shin D, Park J, Kim S, Lim H Diagnostics (Basel). 2023; 13(18).

PMID: 37761270 PMC: 10529363. DOI: 10.3390/diagnostics13182904.


ANO10 is a potential prognostic biomarker and correlates with immune infiltration in breast cancer.

Ning R, Pan S, Xiao D, Zheng Y, Zhang J Am J Cancer Res. 2023; 13(5):1845-1862.

PMID: 37293146 PMC: 10244099.